Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DPI-3290 is a specific agonist of opioid receptors (Ki: 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively) with potent antinociceptive activity. DPI-3290 is one of a series of novel centrally acting agents.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,970.00 | |
50 mg | 8-10 weeks | $ 2,580.00 | |
100 mg | 8-10 weeks | $ 3,400.00 |
Description | DPI-3290 is a specific agonist of opioid receptors (Ki: 0.18 nM, 0.46 nM, and 0.62 nM for δ-, μ-, and κ-opioid receptors, respectively) with potent antinociceptive activity. DPI-3290 is one of a series of novel centrally acting agents. |
Targets&IC50 | μ opioid receptor:0.46 nM, δ opioid receptor:0.18 nM, κ opioid receptor:0.62 nM |
In vivo | In rats, DPI-3290 (i.v; 0.05 mg/kg) produces a 50% antinociceptive response. |
Synonyms | Org 41793 |
Molecular Weight | 487.61 |
Formula | C30H34FN3O2 |
CAS No. | 182417-73-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DPI-3290 182417-73-8 Endocrinology/Hormones GPCR/G Protein Neuroscience Opioid Receptor DPI3290 Org 41793 DPI 3290 inhibitor inhibit